missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ Tn Antigen Monoclonal Antibody (Tn 218)

Description
MA1-90544 stains Tn antigen in epithelial carcinoma, pancreatic, colon, stomach and breast. A suggested positive control for this product is human gastrointestinal tumor. The antibody is supplied as concentrated tissue culture supernatant in PBS with 0.05% azide.
Aberrant glycosylation is a hallmark of cancer cells. The blood group precursors T (Thomsen-Friedenreich) and Tn epitopes are shielded in healthy and benign-diseased tissues but uncovered in approximately 90% of carcinomas. T and Tn glycoproteins are specific, autoimmunogenic pancarcinoma antigens. These antigens may also be found in neoplastic blood cells. Fundamental, chemical and physical aspects of these glycoproteins of primary carcinomas are discussed first. Tn and T epitopes are cell and tissue adhesion molecules, essential in invasion by and metastasis of carcinoma which includes adherent and proliferative phases. Immunohistochemical studies of the extent of Tn antigen expression in primamry breast carcinoma demonstrate its highly significant correlation with clinical pathological tumor stages, and hence its value as a reliable prognisticator.
Specifications
Specifications
| Antigen | Tn Antigen |
| Applications | Immunohistochemistry (Paraffin), Western Blot, Immunocytochemistry |
| Classification | Monoclonal |
| Clone | Tn 218 |
| Concentration | 0.20 mg/mL |
| Conjugate | Unconjugated |
| Formulation | PBS with 0.05% sodium azide; pH 7.2 |
| Gene Alias | Thomsen-Friedenreich antigen |
| Host Species | Mouse |
| Immunogen | Asialo ovine submaxillary mucin (AOSM). |
| Show More |
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?